• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of brmedjBMJ helping doctors make better decisionsSearchLatest content
Br Med J. Mar 22, 1980; 280(6217): 833–836.
PMCID: PMC1601011

Study of information submitted by drug companies to licensing authorities.

Abstract

Reports of clinical trials included in applications submitted by drug companies to licensing authorities in Finland and Sweden in four different years were studied. Many reports were submitted, but most of the trials were uncontrolled and of poor quality. Many of the reports were unpublished, and thus, as the submissions are secret, were not available to doctors. These unpublished reports were in most respects as valuable as the published reports. Most of the reports included some information about adverse effects; the information was often deficient, but skilled analysis might increase its value. This study provides support for those who want to see public disclosure of the reports of trials submitted in licensing applications.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (723K), or click on a page image below to browse page by page.

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

Formats:

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...